000			01316 a2200385 4500
005			20250513205912.0
264		0	_c20000424
008			200004s 0 0 eng d
022			_a0093-7754
040			_aNLM _beng _cNLM
100	1		_aBerg, W J
245	0	0	_aNovel investigative approaches for advanced renal cell carcinoma. _h[electronic resource]
260			_bSeminars in oncology _cApr 2000
300			_a234-9 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdjuvants, Immunologic _xtherapeutic use
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCarcinoma, Renal Cell _xblood supply
650	0	4	_aClinical Trials as Topic
650	0	4	_aCombined Modality Therapy
650	0	4	_aHumans
650	0	4	_aInterferon-alpha _xtherapeutic use
650	0	4	_aInterleukin-2 _xtherapeutic use
650	0	4	_aIsotretinoin _xtherapeutic use
650	0	4	_aKidney Neoplasms _xblood supply
650	0	4	_aNeoplasm Metastasis
650	0	4	_aPrognosis
650	0	4	_aRetinoids _xtherapeutic use
700	1		_aDivgi, C R
700	1		_aNanus, D M
700	1		_aMotzer, R J
773	0		_tSeminars in oncology _gvol. 27 _gno. 2 _gp. 234-9
999			_c10721757 _d10721757